Cargando…
Is the Barcelona Clinic Liver Cancer guideline for treating intermediate to advanced staged hepatocellular carcinoma still appropriate?
Autores principales: | Kang, Koo Jeong, Ahn, Keun Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859792/ https://www.ncbi.nlm.nih.gov/pubmed/33553294 http://dx.doi.org/10.21037/atm-2020-132 |
Ejemplares similares
-
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022) -
Rethinking the Barcelona clinic liver cancer guidelines: Intermediate stage and Child-Pugh B patients are suitable for surgery?
por: Romano, Fabrizio, et al.
Publicado: (2021) -
Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence
por: Koh, Ye Xin, et al.
Publicado: (2018) -
Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
por: Ahn, Keun Soo, et al.
Publicado: (2019) -
Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2022)